Poll: Marylanders unconvinced lower drug costs would hinder research for new treatments

A new poll shows an overhwhelming majority of Marylanders believe drug makers could reduce costs for prescription drugs without cutting into funds for research and development of new drugs, a key argument of the pharmaceutical industry.